Kaleido

Medical Devices & EquipmentSeries DUtrecht, Netherlandshellokaleido.com

Latest round

Series D

Last raised

Jan 2026

Total raised

$182M

Investors

9

About Kaleido

, trading under the name Kaleido an insulin delivery solution aimed at individuals with diabetes. The Kaleido Insulin Pump features customizability with various colors and integrates with the DBLG1 algorithm and Dexcom G6 monitoring system for real-time adjustments.V. developed Kaleido, an insulin delivery solution aimed at individuals with diabetes. The Kaleido Insulin Pump features customizability with various colors and integrates with the DBLG1 algorithm and Dexcom G6 monitoring system for real-time adjustments. Currently, these products are primarily available in Germany and the Netherlands, catering to adults with diabetes and their healthcare providers while prioritizing ease of use and sustainability.V. reported a revenue of EUR 1,503,364 with an EBITDA of EUR -10,266,035, generated mainly from the sales of its insulin pumps and consumables, including a Starter Kit offering two pumps with a four-year warranty.

Who invested in Kaleido

9 investors across 5 rounds

See all investors in Kaleido

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series D

    Jan 8, 2026

    Amount

    $13M

    Investors

    Locked

  2. Series D

    Sep 3, 2025

    Amount

    $85M

    Investors

    Locked

  3. Series C

    Dec 16, 2021

    Amount

    $73M

    Investors

    Locked

  4. Series B

    Jun 1, 2015

    Amount

    $11M

    Investors

    Locked

  5. Seed

    Mar 12, 2013

    Amount

    Undisclosed

    Investors

    Locked

Questions about Kaleido

Who invested in Kaleido?

Kaleido has 9 investors on record across 5 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Kaleido raised?

Kaleido has raised 5 venture rounds. Sign up free to see how much each round raised and the total.

When did Kaleido last raise money?

Kaleido's most recent round on record is a Series D, in Jan 2026.

What does Kaleido do?

, trading under the name Kaleido an insulin delivery solution aimed at individuals with diabetes.

Where is Kaleido headquartered?

Kaleido is headquartered in Utrecht, Netherlands.

Which VCs invest in companies like Kaleido?

Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back medical devices & equipment companies at Kaleido's stage. Their profiles are linked below.

Raising like Kaleido? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.